These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38419575)

  • 1. Prediagnostic evaluation of multicancer detection tests: design and analysis considerations.
    Baker SG; Etzioni R
    J Natl Cancer Inst; 2024 Jun; 116(6):795-799. PubMed ID: 38419575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Screening Markers: A Simple Strategy to Substantially Reduce the Sample Size for Validation.
    Baker SG
    Med Decis Making; 2019 Feb; 39(2):130-136. PubMed ID: 30658540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum T3 levels are associated with false-positive results when using the risk of ovarian malignancy algorithm (ROMA) in women with benign ovarian disease.
    Park H; Lee DW; Kim MJ; Shin JE; Lee HN
    Taiwan J Obstet Gynecol; 2021 Jan; 60(1):36-40. PubMed ID: 33495005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trials of multicancer screening tests: augmenting their ability to identify a genuine mortality benefit.
    Weiss NS
    J Natl Cancer Inst; 2024 Jul; 116(7):1005-1007. PubMed ID: 38449292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer.
    Young GP; Senore C; Mandel JS; Allison JE; Atkin WS; Benamouzig R; Bossuyt PM; Silva MD; Guittet L; Halloran SP; Haug U; Hoff G; Itzkowitz SH; Leja M; Levin B; Meijer GA; O'Morain CA; Parry S; Rabeneck L; Rozen P; Saito H; Schoen RE; Seaman HE; Steele RJ; Sung JJ; Winawer SJ
    Cancer; 2016 Mar; 122(6):826-39. PubMed ID: 26828588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.
    Doroudi M; Kramer BS; Pinsky PF
    J Med Screen; 2017 Dec; 24(4):220-222. PubMed ID: 27903809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPIC Early Detection of Ovarian Cancer.
    Skates SJ
    Clin Cancer Res; 2016 Sep; 22(18):4542-4. PubMed ID: 27418634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifiable TCR repertoire changes in prediagnostic blood specimens among patients with high-grade ovarian cancer.
    Yu X; Pan M; Ye J; Hathaway CA; Tworoger SS; Lea J; Li B
    Cell Rep Med; 2024 Jul; 5(7):101612. PubMed ID: 38878776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank.
    Gislefoss RE; Langseth H; Bolstad N; Nustad K; Mørkrid L
    Int J Gynecol Cancer; 2015 Nov; 25(9):1608-15. PubMed ID: 26501436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer: Missing the mark.
    Buchen L
    Nature; 2011 Mar; 471(7339):428-32. PubMed ID: 21430749
    [No Abstract]   [Full Text] [Related]  

  • 11. Identifying combinations of cancer markers for further study as triggers of early intervention.
    Baker SG
    Biometrics; 2000 Dec; 56(4):1082-7. PubMed ID: 11129464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Moore LE; Pfeiffer RM; Zhang Z; Lu KH; Fung ET; Bast RC
    Cancer; 2012 Jan; 118(1):91-100. PubMed ID: 21717433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
    Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
    Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
    Simmons AR; Fourkala EO; Gentry-Maharaj A; Ryan A; Sutton MN; Baggerly K; Zheng H; Lu KH; Jacobs I; Skates S; Menon U; Bast RC
    Cancer Prev Res (Phila); 2019 Jun; 12(6):391-400. PubMed ID: 30967390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.
    Schrag D; Beer TM; McDonnell CH; Nadauld L; Dilaveri CA; Reid R; Marinac CR; Chung KC; Lopatin M; Fung ET; Klein EA
    Lancet; 2023 Oct; 402(10409):1251-1260. PubMed ID: 37805216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers.
    Trinidad CV; Tetlow AL; Bantis LE; Godwin AK
    Cancer Prev Res (Phila); 2020 Mar; 13(3):241-252. PubMed ID: 32132118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.
    Anderson GL; McIntosh M; Wu L; Barnett M; Goodman G; Thorpe JD; Bergan L; Thornquist MD; Scholler N; Kim N; O'Briant K; Drescher C; Urban N
    J Natl Cancer Inst; 2010 Jan; 102(1):26-38. PubMed ID: 20042715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.